Investing.com
_news_article_title_published Mar 14, 2024 06:06PM ET
Investing.com - aTyr Pharma (NASDAQ: LIFE) reported first quarter EPS of $-0.250, $0.01 worse than the analyst estimate of $-0.240. Revenue for the quarter came in at $260K versus the consensus estimate of $3.42M.
h2 /h2
aTyr Pharma's stock price closed at $1.620. It is up 32.790% in the last 3 months and down -17.770% in the last 12 months.
aTyr Pharma saw 2 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See aTyr Pharma's stock price’s past reactions to earnings here .
According to fair performance ".
Check out aTyr Pharma's recent earnings performance, and aTyr Pharma's financials here .
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
_newTouch_News_Source: Investing.com
_touchRiskDisclosure_message